| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 3,171,500 | 3,260,800 | 3,033,300 | | Cost of Revenue | 1,144,200 | 1,176,200 | 1,140,200 | | | Gross Profit | 2,027,300 | 2,084,600 | 1,893,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 387,500 | 412,100 | 495,300 | | Non Recurring | 14,700 | 13,900 | 49,400 | | Others | 492,700 | 507,500 | 449,600 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 1,132,400 | 1,151,100 | 898,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,100 | 462,400 | 32,700 | | Earnings Before Interest And Taxes | 1,134,500 | 1,613,500 | 931,500 | | Interest Expense | 416,400 | 444,400 | 209,600 | | Income Before Tax | 718,100 | 1,169,100 | 721,900 | | Income Tax Expense | 283,200 | 252,000 | 276,300 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 434,900 | 917,100 | 445,600 | | | Non-recurring Events | | Discontinued Operations | (22,200) |
-
|
-
| | Extraordinary Items |
-
|
-
| 99,700 | | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 412,700 | 917,100 | 545,300 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $412,700 | $917,100 | $545,300 |
|
1.52% Nasdaq 0.00%
Income Statement
